NCT05621369Active, not recruiting
Psorcast Mobile Study
Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 10 Nov 2022
- Start date
- 1 Jan 2022
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Sage Bionetworks
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT05621369
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2022 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age 17 years or younger
Other
- Not a resident of the a country where the app is approved for use
- Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
- Not be able to read and understand an official language of the country of participation
Who the study is looking for
- Adult age 18 and older who consent to participate in the study
- Own a compatible iPhone or iPod Touch device running iOS 12.2 or above
- Be able to read and understand an official language of the country of participation
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sage Bionetworks Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.